Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Dangerous liaisons in anaphylaxis.

Levi-Schaffer F, Scheffel J.

Science. 2018 Nov 9;362(6415):640-641. doi: 10.1126/science.aav4505. No abstract available.

PMID:
30409871
2.

Fevipiprant, a DP2 Receptor Antagonist, Inhibits Eosinophil Migration Towards Mast Cells.

Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F.

Clin Exp Allergy. 2018 Oct 31. doi: 10.1111/cea.13304. [Epub ahead of print]

PMID:
30379368
3.

2B4 and CD48: A powerful couple of the immune system.

Pahima H, Puzzovio PG, Levi-Schaffer F.

Clin Immunol. 2018 Oct 24. pii: S1521-6616(18)30579-5. doi: 10.1016/j.clim.2018.10.014. [Epub ahead of print] Review.

PMID:
30366105
4.

Comparing biologicals and small molecule drug therapies for chronic respiratory diseases.

Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Caramori G, Cari L, Chung KF, Diamant Z, Eguiluz-Gracia I, Knol E, Kolios A, Levi-Schaffer F, Nocentini G, Palomares O, Puzzovio PG, Redegeld F, Van Esch B, Stellato C.

Allergy. 2018 Oct 24. doi: 10.1111/all.13642. [Epub ahead of print]

PMID:
30353939
5.

Leukocyte CD300a Contributes to the Resolution of Murine Allergic Inflammation.

Karra L, Singh Gangwar R, Shamri R, Puzzovio PG, Cohen-Mor S, Levy BD, Levi-Schaffer F.

J Immunol. 2018 Nov 15;201(10):2998-3005. doi: 10.4049/jimmunol.1801000. Epub 2018 Oct 12.

PMID:
30315138
6.

Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study.

Breuer O, Gangwar RS, Seaf M, Barhoum A, Kerem E, Levi-Schaffer F.

J Immunol Res. 2018 Sep 16;2018:4236263. doi: 10.1155/2018/4236263. eCollection 2018.

7.

Modulation of allergic responses by mitochondrial STAT3 inhibitors.

Erlich TH, Sharkia I, Landolina N, Assayag M, Goldberger O, Berkman N, Levi-Schaffer F, Razin E.

Allergy. 2018 Nov;73(11):2160-2171. doi: 10.1111/all.13467. Epub 2018 Oct 30.

PMID:
29683527
8.

Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab.

Cazzola M, Matera MG, Levi-Schaffer F, Rogliani P.

Expert Opin Drug Saf. 2018 Apr;17(4):429-435. doi: 10.1080/14740338.2018.1446940. Epub 2018 Mar 8. Review.

PMID:
29486600
9.

Human eosinophils and mast cells: Birds of a feather flock together.

Robida PA, Puzzovio PG, Pahima H, Levi-Schaffer F, Bochner BS.

Immunol Rev. 2018 Mar;282(1):151-167. doi: 10.1111/imr.12638. Review.

PMID:
29431215
10.

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Harding SD, Sharman JL, Faccenda E, Southan C, Pawson AJ, Ireland S, Gray AJG, Bruce L, Alexander SPH, Anderton S, Bryant C, Davenport AP, Doerig C, Fabbro D, Levi-Schaffer F, Spedding M, Davies JA; NC-IUPHAR.

Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.

11.

Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours.

Levi-Schaffer F, Mandelboim O.

Trends Immunol. 2018 Feb;39(2):112-122. doi: 10.1016/j.it.2017.10.001. Epub 2017 Oct 20. Review.

PMID:
29066058
12.

AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.

Jensen-Jarolim E, Bax HJ, Bianchini R, Crescioli S, Daniels-Wells TR, Dombrowicz D, Fiebiger E, Gould HJ, Irshad S, Janda J, Josephs DH, Levi-Schaffer F, O'Mahony L, Pellizzari G, Penichet ML, Redegeld F, Roth-Walter F, Singer J, Untersmayr E, Vangelista L, Karagiannis SN.

Allergy. 2018 Feb;73(2):328-340. doi: 10.1111/all.13311. Epub 2017 Oct 5.

PMID:
28921585
13.

MicroRNA-4443 regulates mast cell activation by T cell-derived microvesicles.

Shefler I, Salamon P, Levi-Schaffer F, Mor A, Hershko AY, Mekori YA.

J Allergy Clin Immunol. 2018 Jun;141(6):2132-2141.e4. doi: 10.1016/j.jaci.2017.06.045. Epub 2017 Aug 16.

PMID:
28823811
14.

Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.

Galdiero MR, Varricchi G, Seaf M, Marone G, Levi-Schaffer F, Marone G.

Front Med (Lausanne). 2017 Jul 24;4:103. doi: 10.3389/fmed.2017.00103. eCollection 2017. Review.

15.

In Memory and Celebration: Dr. James J. Lee.

Rosenberg HF, Fryer AD, Munitz A, Bochner BS, Jacoby DB, Levi-Schaffer F, Gleich GJ, Furuta GT, Rothenberg ME, Lacy P, Fulkerson PC, Hogan SP, Ackerman SJ, Foster PS.

Clin Exp Allergy. 2017 Jul;47(7):980-981. doi: 10.1111/cea.12959. No abstract available.

PMID:
28547822
16.

Positive and Negative Signals in Mast Cell Activation.

Bulfone-Paus S, Nilsson G, Draber P, Blank U, Levi-Schaffer F.

Trends Immunol. 2017 Sep;38(9):657-667. doi: 10.1016/j.it.2017.01.008. Epub 2017 Feb 20. Review.

PMID:
28254170
17.

AllergoOncology - the impact of allergy in oncology: EAACI position paper.

Jensen-Jarolim E, Bax HJ, Bianchini R, Capron M, Corrigan C, Castells M, Dombrowicz D, Daniels-Wells TR, Fazekas J, Fiebiger E, Gatault S, Gould HJ, Janda J, Josephs DH, Karagiannis P, Levi-Schaffer F, Meshcheryakova A, Mechtcheriakova D, Mekori Y, Mungenast F, Nigro EA, Penichet ML, Redegeld F, Saul L, Singer J, Spicer JF, Siccardi AG, Spillner E, Turner MC, Untersmayr E, Vangelista L, Karagiannis SN.

Allergy. 2017 Jun;72(6):866-887. doi: 10.1111/all.13119. Epub 2017 Jan 23. Review.

18.

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN).

Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sánchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW; Interasma Executive Board; WAO Board of Directors; ARIA; GA²LEN.

Asthma Res Pract. 2016 Oct 28;2:12. eCollection 2016.

19.

Pyruvate dehydrogenase has a major role in mast cell function, and its activity is regulated by mitochondrial microphthalmia transcription factor.

Sharkia I, Hadad Erlich T, Landolina N, Assayag M, Motzik A, Rachmin I, Kay G, Porat Z, Tshori S, Berkman N, Levi-Schaffer F, Razin E.

J Allergy Clin Immunol. 2017 Jul;140(1):204-214.e8. doi: 10.1016/j.jaci.2016.09.047. Epub 2016 Nov 18.

PMID:
27871875
20.

CD48 on blood leukocytes and in serum of asthma patients varies with severity.

Gangwar RS, Minai-Fleminger Y, Seaf M, Gutgold A, Shikotra A, Barber C, Chauhan A, Holgate S, Bradding P, Howarth P, Eliashar R, Berkman N, Levi-Schaffer F.

Allergy. 2017 Jun;72(6):888-895. doi: 10.1111/all.13082. Epub 2016 Dec 1. Erratum in: Allergy. 2017 Oct;72 (10 ):1591.

PMID:
27859399
21.

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN).

Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sanchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW, Cruz A, Yanez A, Yorgancioglu A, Deleanu D, Rodrigo G, Berstein J, Ohta K, Vichyanond P, Pawankar R, Gonzalez-Diaz SN, Nakajima S, Slavyanskaya T, Fink-Wagner A, Loyola CB, Ryan D, Passalacqua G, Celedon J, Ivancevich JC, Dobashi K, Zernotti M, Akdis M, Benjaponpitak S, Bonini S, Burks W, Caraballo L, El-Sayed ZA, Fineman S, Greenberger P, Hossny E, Ortega-Martell JA, Saito H, Tang M, Zhang L; for Interasma Executive Board; ARIA; GA2LEN.

World Allergy Organ J. 2016 Oct 28;9(1):37. eCollection 2016.

22.

Mast cell and eosinophil surface receptors as targets for anti-allergic therapy.

Gangwar RS, Landolina N, Arpinati L, Levi-Schaffer F.

Pharmacol Ther. 2017 Feb;170:37-63. doi: 10.1016/j.pharmthera.2016.10.010. Epub 2016 Oct 20. Review. No abstract available.

PMID:
27773785
23.

Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells.

Schmiedel D, Tai J, Levi-Schaffer F, Dovrat S, Mandelboim O.

J Virol. 2016 Oct 14;90(21):9608-9617. Print 2016 Nov 1.

24.

Papain Activates Human Mast Cells to Release Proinflammatory Mediators via its Enzymatic Activity.

Seaf M, Ben-Zimra M, Mankuta D, Dayan N, Levi-Schaffer F.

J Invest Dermatol. 2016 Jul;136(7):1523-1525. doi: 10.1016/j.jid.2016.03.030. Epub 2016 Apr 7. No abstract available.

25.

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity.

Duev-Cohen A, Bar-On Y, Glasner A, Berhani O, Ophir Y, Levi-Schaffer F, Mandelboim M, Mandelboim O.

Oncotarget. 2016 Mar 15;7(11):13093-105. doi: 10.18632/oncotarget.7597.

26.

Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion AD, Leiferman KM, Levi-Schaffer F, Nilsson G, Okayama Y, Prussin C, Schroeder JT, Schwartz LB, Simon HU, Walls AF, Triggiani M.

World Allergy Organ J. 2016 Feb 11;9:7. doi: 10.1186/s40413-016-0094-3. eCollection 2016. Review.

27.

sCD48 is anti-inflammatory in Staphylococcus aureus Enterotoxin B-induced eosinophilic inflammation.

Gangwar RS, Levi-Schaffer F.

Allergy. 2016 Jun;71(6):829-39. doi: 10.1111/all.12851. Epub 2016 Feb 26.

PMID:
26836239
28.

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.

Carvalho S, Levi-Schaffer F, Sela M, Yarden Y.

Br J Pharmacol. 2016 May;173(9):1407-24. doi: 10.1111/bph.13450. Epub 2016 Mar 14. Review.

29.

Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.

Landolina N, Levi-Schaffer F.

Br J Pharmacol. 2016 Mar;173(5):793-803. doi: 10.1111/bph.13396. Epub 2016 Feb 1. Review.

30.

Pharmacological research and precision cancer medicine: A call for manuscripts.

Cho K, Clementi E, Levi-Schaffer F, Smalley KS, Radice S, Watts SW.

Pharmacol Res. 2015 Dec;102:308-9. doi: 10.1016/j.phrs.2015.10.016. Epub 2015 Nov 2. No abstract available.

PMID:
26542638
31.

Mast cells and eosinophils in allergy: Close friends or just neighbors.

Gangwar RS, Friedman S, Seaf M, Levi-Schaffer F.

Eur J Pharmacol. 2016 May 5;778:77-83. doi: 10.1016/j.ejphar.2015.10.036. Epub 2015 Oct 23. Review.

PMID:
26526347
32.

Introducing a checklist for manuscript submission to Pharmacological Research.

Cho K, Clementi E, Levi-Schaffer F, Smalley KS, Radice S, Watts SW.

Pharmacol Res. 2015 Dec;102:319-21. doi: 10.1016/j.phrs.2015.10.017. Epub 2015 Oct 30. No abstract available.

PMID:
26523875
33.

Substance P and eosinophils: an itchy connection.

Friedman S, Levi-Schaffer F.

Exp Dermatol. 2015 Dec;24(12):918-9. doi: 10.1111/exd.12806. Epub 2015 Aug 28. No abstract available.

PMID:
26174197
34.

The expanding role of immunopharmacology: IUPHAR Review 16.

Tiligada E, Ishii M, Riccardi C, Spedding M, Simon HU, Teixeira MM, Cuervo ML, Holgate ST, Levi-Schaffer F.

Br J Pharmacol. 2015 Sep;172(17):4217-27. doi: 10.1111/bph.13219. Epub 2015 Jul 21. Review.

35.

Mast cells' integrated actions with eosinophils and fibroblasts in allergic inflammation: implications for therapy.

Landolina N, Gangwar RS, Levi-Schaffer F.

Adv Immunol. 2015;125:41-85. doi: 10.1016/bs.ai.2014.09.002. Epub 2015 Jan 2. Review.

PMID:
25591464
36.

Author response to 'Staphylococcus aureus and primary lysis of eosinophils' by Dr Persson.

Shamri R, Minai-Fleminger Y, Gangwar RS, Migalovich-Sheikhet H, Seaf M, Levi-Schaffer F.

Clin Exp Allergy. 2015 Feb;45(2):490-1. doi: 10.1111/cea.12479. No abstract available.

PMID:
25565468
37.

Lipoxin B₄ promotes the resolution of allergic inflammation in the upper and lower airways of mice.

Karra L, Haworth O, Priluck R, Levy BD, Levi-Schaffer F.

Mucosal Immunol. 2015 Jul;8(4):852-62. doi: 10.1038/mi.2014.116. Epub 2014 Dec 3.

38.

The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation.

Minai-Fleminger Y, Gangwar RS, Migalovich-Sheikhet H, Seaf M, Leibovici V, Hollander N, Feld M, Moses AE, Homey B, Levi-Schaffer F.

Clin Exp Allergy. 2014 Nov;44(11):1335-46. doi: 10.1111/cea.12422.

PMID:
25255823
39.

The search for mast cell and basophil models--are we getting closer to pathophysiological relevance?

Siebenhaar F, Falcone FH, Tiligada E, Hammel I, Maurer M, Sagi-Eisenberg R, Levi-Schaffer F.

Allergy. 2015 Jan;70(1):1-5. doi: 10.1111/all.12517. No abstract available.

PMID:
25155287
40.

Eosinophils as a pharmacological target for the treatment of allergic diseases.

Landolina NA, Levi-Schaffer F.

Curr Opin Pharmacol. 2014 Aug;17:71-80. doi: 10.1016/j.coph.2014.07.014. Epub 2014 Aug 14. Review.

PMID:
25128782
41.

Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation.

Elishmereni M, Fyhrquist N, Singh Gangwar R, Lehtimäki S, Alenius H, Levi-Schaffer F.

J Invest Dermatol. 2014 Dec;134(12):2928-2937. doi: 10.1038/jid.2014.280. Epub 2014 Jul 7.

42.

Eosinophils interaction with mast cells: the allergic effector unit.

Gangwar RS, Levi-Schaffer F.

Methods Mol Biol. 2014;1178:231-49. doi: 10.1007/978-1-4939-1016-8_20.

PMID:
24986621
43.

Siglec-7 is an inhibitory receptor on human mast cells and basophils.

Mizrahi S, Gibbs BF, Karra L, Ben-Zimra M, Levi-Schaffer F.

J Allergy Clin Immunol. 2014 Jul;134(1):230-3. doi: 10.1016/j.jaci.2014.03.031. Epub 2014 May 5. No abstract available.

PMID:
24810846
44.

Molecular targets on mast cells and basophils for novel therapies.

Harvima IT, Levi-Schaffer F, Draber P, Friedman S, Polakovicova I, Gibbs BF, Blank U, Nilsson G, Maurer M.

J Allergy Clin Immunol. 2014 Sep;134(3):530-44. doi: 10.1016/j.jaci.2014.03.007. Epub 2014 Apr 24. Review.

PMID:
24767877
45.

Mitochondrial STAT3 plays a major role in IgE-antigen-mediated mast cell exocytosis.

Erlich TH, Yagil Z, Kay G, Peretz A, Migalovich-Sheikhet H, Tshori S, Nechushtan H, Levi-Schaffer F, Saada A, Razin E.

J Allergy Clin Immunol. 2014 Aug;134(2):460-9. doi: 10.1016/j.jaci.2013.12.1075. Epub 2014 Feb 28.

PMID:
24582310
46.

Proteolytic histone modification by mast cell tryptase, a serglycin proteoglycan-dependent secretory granule protease.

Melo FR, Vita F, Berent-Maoz B, Levi-Schaffer F, Zabucchi G, Pejler G.

J Biol Chem. 2014 Mar 14;289(11):7682-90. doi: 10.1074/jbc.M113.546895. Epub 2014 Jan 29.

47.

Roles of eosinophils in the modulation of angiogenesis.

Nissim Ben Efraim AH, Levi-Schaffer F.

Chem Immunol Allergy. 2014;99:138-54. doi: 10.1159/000353251. Epub 2013 Oct 17. Review.

PMID:
24217607
48.

Eosinophil major basic protein activates human cord blood mast cells primed with fibroblast membranes by integrin-β1.

Ben-Zimra M, Bachelet I, Seaf M, Gleich GJ, Levi-Schaffer F.

Allergy. 2013 Oct;68(10):1259-68. doi: 10.1111/all.12232. Epub 2013 Sep 21.

PMID:
24112102
49.

The inhibitory receptor CD300a is up-regulated by hypoxia and GM-CSF in human peripheral blood eosinophils.

Nissim Ben Efraim AH, Karra L, Ben-Zimra M, Levi-Schaffer F.

Allergy. 2013 Mar;68(3):397-401. doi: 10.1111/all.12092. Epub 2013 Jan 25.

PMID:
23346884
50.

Dexamethasone and salbutamol stimulate human lung fibroblast proliferation.

Pickholtz E, Admon D, Izhar U, Berkman N, Levi-Schaffer F.

World Allergy Organ J. 2011 Dec;4(12):249-56. doi: 10.1097/WOX.0b013e31821d1186.. Epub 2011 Dec 14.

Supplemental Content

Loading ...
Support Center